Company intelligence / Profile preview

Swiss PharmaCan

Frauenfeld, Thurgau, Switzerland

Ownership: Private
Employees: ~30
Development stage: Other

Overview

Swiss PharmaCan markets nutraceuticals with improved bioavailability using MyCell Technology, with in-vivo clinical evidence supporting immune, regeneration, and longevity benefits[5][3]. Over 300 compounds and several product lines have been clinically validated for efficacy and fast absorption[4][5].

Therapeutic areas: ImmunologyDermatologyOther
Modalities: Oil in water emulsionMicellized plant extractPlant oilNutraceutical (non-drug, dietary supplement)
Industry: Food & Nutrition

Beyond the preview

Go deeper on Swiss PharmaCan.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Swiss PharmaCan.

Explore the full profile